125 related articles for article (PubMed ID: 36184893)
1. Genomic profiling with whole-exome sequencing revealed distinct mutations and novel pathways in Asian melanoma.
Chiu YJ; Weng HY; Lin YY; Lin YF; Yeh YC; Perng CK; Ma H; Tsai SF; Chou TY
J Dermatol; 2022 Dec; 49(12):1299-1309. PubMed ID: 36184893
[TBL] [Abstract][Full Text] [Related]
2. Integrative Genomic Profiling Uncovers Therapeutic Targets of Acral Melanoma in Asian Populations.
Shi Q; Liu L; Chen J; Zhang W; Guo W; Wang X; Wang H; Guo S; Yue Q; Ma J; Liu Y; Zhu G; Zhao T; Zhao J; Liu Y; Gao T; Li C
Clin Cancer Res; 2022 Jun; 28(12):2690-2703. PubMed ID: 35294533
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive genomic analysis of primary malignant melanoma of the esophagus reveals similar genetic patterns compared with epithelium-associated melanomas.
Li J; Liu B; Ye Q; Xiao X; Yan S; Guan W; He L; Wang C; Yu Z; Tai Z; Pei S; Ma Y; Li S; Wang Y; Wu N
Mod Pathol; 2022 Nov; 35(11):1596-1608. PubMed ID: 35688970
[TBL] [Abstract][Full Text] [Related]
4. Targeted Genomic Profiling of Acral Melanoma.
Yeh I; Jorgenson E; Shen L; Xu M; North JP; Shain AH; Reuss D; Wu H; Robinson WA; Olshen A; von Deimling A; Kwok PY; Bastian BC; Asgari MM
J Natl Cancer Inst; 2019 Oct; 111(10):1068-1077. PubMed ID: 30657954
[TBL] [Abstract][Full Text] [Related]
5. TERT promoter mutation is uncommon in acral lentiginous melanoma.
Liau JY; Tsai JH; Jeng YM; Chu CY; Kuo KT; Liang CW
J Cutan Pathol; 2014 Jun; 41(6):504-8. PubMed ID: 24588324
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive genomic characterization of cutaneous malignant melanoma cell lines derived from metastatic lesions by whole-exome sequencing and SNP array profiling.
Cifola I; Pietrelli A; Consolandi C; Severgnini M; Mangano E; Russo V; De Bellis G; Battaglia C
PLoS One; 2013; 8(5):e63597. PubMed ID: 23704925
[TBL] [Abstract][Full Text] [Related]
7. Mutational profiling of acral melanomas in Korean populations.
Shim JH; Shin HT; Park J; Park JH; Lee JH; Yang JM; Kim DH; Jang KT; Lee DY
Exp Dermatol; 2017 Oct; 26(10):883-888. PubMed ID: 28191690
[TBL] [Abstract][Full Text] [Related]
8. Distinct genomic features in a retrospective cohort of mucosal, acral, and vulvovaginal melanomas.
Shi K; Zhang B; Kong BY; Zhang Y; Igartua C; Mohan LS; Quan VL; Panah E; Isales MC; Beaubier N; Taxter TJ; White KP; Zou L; Gerami P
J Am Acad Dermatol; 2023 May; 88(5):1051-1059. PubMed ID: 31306728
[TBL] [Abstract][Full Text] [Related]
9. Meta-Analysis and Systematic Review of the Genomics of Mucosal Melanoma.
Broit N; Johansson PA; Rodgers CB; Walpole ST; Newell F; Hayward NK; Pritchard AL
Mol Cancer Res; 2021 Jun; 19(6):991-1004. PubMed ID: 33707307
[TBL] [Abstract][Full Text] [Related]
10. Genomic characterisation of acral melanoma cell lines.
Furney SJ; Turajlic S; Fenwick K; Lambros MB; MacKay A; Ricken G; Mitsopoulos C; Kozarewa I; Hakas J; Zvelebil M; Lord CJ; Ashworth A; Reis-Filho JS; Herlyn M; Murata H; Marais R
Pigment Cell Melanoma Res; 2012 Jul; 25(4):488-92. PubMed ID: 22578220
[TBL] [Abstract][Full Text] [Related]
11. Distinct MAPK and PI3K pathway mutations in different melanoma types in Taiwanese individuals.
Gao HW; Tsai WC; Perng CL; Wang WM; Chiang CP
Eur J Dermatol; 2018 Aug; 28(4):509-518. PubMed ID: 30325319
[TBL] [Abstract][Full Text] [Related]
12. Distinct genomic traits of acral and mucosal melanomas revealed by targeted mutational profiling.
Zou Z; Ou Q; Ren Y; Lv Q; Qin L; Zhao L; Su S; Wu X; Bao H; Wang A; Zhu D; Wang X; Shao YW; Liu B
Pigment Cell Melanoma Res; 2020 Jul; 33(4):601-611. PubMed ID: 31944535
[TBL] [Abstract][Full Text] [Related]
13. The mutational burden of acral melanoma revealed by whole-genome sequencing and comparative analysis.
Furney SJ; Turajlic S; Stamp G; Thomas JM; Hayes A; Strauss D; Gavrielides M; Xing W; Gore M; Larkin J; Marais R
Pigment Cell Melanoma Res; 2014 Sep; 27(5):835-8. PubMed ID: 24913711
[TBL] [Abstract][Full Text] [Related]
14. Patterns of genomic evolution in advanced melanoma.
Birkeland E; Zhang S; Poduval D; Geisler J; Nakken S; Vodak D; Meza-Zepeda LA; Hovig E; Myklebost O; Knappskog S; Lønning PE
Nat Commun; 2018 Jul; 9(1):2665. PubMed ID: 29991680
[TBL] [Abstract][Full Text] [Related]
15. Integrated genomic analyses of acral and mucosal melanomas nominate novel driver genes.
Wang M; Banik I; Shain AH; Yeh I; Bastian BC
Genome Med; 2022 Jun; 14(1):65. PubMed ID: 35706047
[TBL] [Abstract][Full Text] [Related]
16. Determination of the mutational landscape in Taiwanese patients with papillary thyroid cancer by whole-exome sequencing.
Chang CC; Chang YS; Huang HY; Yeh KT; Liu TC; Chang JG
Hum Pathol; 2018 Aug; 78():151-158. PubMed ID: 29753010
[TBL] [Abstract][Full Text] [Related]
17. GNAQ and GNA11 mutant nonuveal melanoma: a subtype distinct from both cutaneous and uveal melanoma.
Livingstone E; Zaremba A; Horn S; Ugurel S; Casalini B; Schlaak M; Hassel JC; Herbst R; Utikal JS; Weide B; Gutzmer R; Meier F; Koelsche C; Hadaschik E; Sucker A; Reis H; Merkelbach-Bruse S; Siewert M; Sahm F; von Deimling A; Cosgarea I; Zimmer L; Schadendorf D; Schilling B; Griewank KG
Br J Dermatol; 2020 Nov; 183(5):928-939. PubMed ID: 32064597
[TBL] [Abstract][Full Text] [Related]
18. Genetic Alterations in Primary Acral Melanoma and Acral Melanocytic Nevus in Korea: Common Mutated Genes Show Distinct Cytomorphological Features.
Moon KR; Choi YD; Kim JM; Jin S; Shin MH; Shim HJ; Lee JB; Yun SJ
J Invest Dermatol; 2018 Apr; 138(4):933-945. PubMed ID: 29191620
[TBL] [Abstract][Full Text] [Related]
19. Whole genome sequencing of melanomas in adolescent and young adults reveals distinct mutation landscapes and the potential role of germline variants in disease susceptibility.
Wilmott JS; Johansson PA; Newell F; Waddell N; Ferguson P; Quek C; Patch AM; Nones K; Shang P; Pritchard AL; Kazakoff S; Holmes O; Leonard C; Wood S; Xu Q; Saw RPM; Spillane AJ; Stretch JR; Shannon KF; Kefford RF; Menzies AM; Long GV; Thompson JF; Pearson JV; Mann GJ; Hayward NK; Scolyer RA
Int J Cancer; 2019 Mar; 144(5):1049-1060. PubMed ID: 30178487
[TBL] [Abstract][Full Text] [Related]
20. NF1-mutated melanomas reveal distinct clinical characteristics depending on tumour origin and respond favourably to immune checkpoint inhibitors.
Thielmann CM; Chorti E; Matull J; Murali R; Zaremba A; Lodde G; Jansen P; Richter L; Kretz J; Möller I; Sucker A; Herbst R; Terheyden P; Utikal J; Pföhler C; Ulrich J; Kreuter A; Mohr P; Gutzmer R; Meier F; Dippel E; Weichenthal M; Paschen A; Livingstone E; Zimmer L; Schadendorf D; Hadaschik E; Ugurel S; Griewank KG
Eur J Cancer; 2021 Dec; 159():113-124. PubMed ID: 34742158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
